Clinical outcomes and predictors for ESRD and mortality in primary GN

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 9, 2012, Pages 1401-1408

  Chou, Yu Hsiang ^a   Lien, Yu Chung ^b   Hu, Fu Chang ^a,c   Lin, Wei Chou ^a   Kao, Chih Chin ^a   Lai, Chun Fu ^a   Chiang, Wen Chih ^a   Lin, Shuei Liong ^a   Tsai, Tun Jun ^a   Wu, Kwan Dun ^a   Chen, Yung Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; DIALYSIS; FEMALE; FOCAL GLOMERULONEPHRITIS; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MORTALITY; OUTCOME ASSESSMENT; PREDICTION;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEMOGLOBINS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEPHROSIS, LIPOID; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84866113525     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04500511     Document Type: Article

References (44)

1. Lysaght MJ: Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol 13[Suppl 1]: S37-S40, 2002
2. Moeller S, Gioberge S, Brown G: ESRD patients in 2001: Global overview of patients, treatment modalities and development trends. Nephrol Dial Transplant 17: 2071-2076, 2002
3. Francesco PS: Epidemiology of end-stage renal disease: International comparisons of dialysis. Kidney Int Suppl 57: S39-S45, 2000
4. Rivera F, López-Gómez JM, Pérez-García R; Spanish Registry of Glomerulonephritis: Clinicopathologic correlations of renal pathology in Spain. Kidney Int 66: 898-904, 2004
5. D'Amico G: Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature. Am J Kidney Dis 20: 315-323, 1992
6. Deegens JK, Wetzels JF: Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy. Minerva Urol Nefrol 57: 211-236, 2005
7. Moranne O, Watier L, Rossert J, Stengel B; GN-Progress Study Group: Primary glomerulonephritis: An update on renal survival and determinants of progression. QJM 101: 215-224, 2008
8. Heaf J, Løkkegaard H, Larsen S: The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997. Nephrol Dial Transplant 14: 1889-1897, 1999
9. Simon P, Ramee MP, Boulahrouz R, Stanescu C, Charasse C, Ang KS, Leonetti F, Cam G, Laruelle E, Autuly V, Rioux N: Epidemiologic data of primary glomerular diseases in western France. Kidney Int 66: 905-908, 2004
10. Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S; Genes, Gender and Glomerulonephritis Group: The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant 23: 2247-2253, 2008
11. Cai GY, Chen XM: Immunoglobulin A nephropathy in China: Progress and challenges. Am J Nephrol 30: 268-273, 2009
12. Zhou FD, Zhao MH, Zou WZ, Liu G, Wang H: The changing spectrum of primary glomerular diseases within 15 years: A survey of 3331 patients in a single Chinese centre. Nephrol Dial Transplant 24: 870-876, 2009
13. Research Group on Progressive Chronic Renal Disease: Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Nephron 82: 205-213, 1999
14. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876, 2004
15. Chang JH, Kim DK, Kim HW, Park SY, Yoo TH, Kim BS, Kang SW, Choi KH, Han DS, Jeong HJ, Lee HY: Changing prevalence of glomerular diseases in Korean adults: A review of 20 years of experience. Nephrol Dial Transplant 24: 2406-2410, 2009
16. Woo KT, Chiang GS, Edmondson RP, Wu AY, Lee EJ, Pwee HS, Lim CH: Glomerulonephritis in Singapore: An overview. Ann Acad Med Singapore 15: 20-31, 1986
17. Kazi JI, Mubarak M, Ahmed E, Akhter F, Naqvi SA, Rizvi SA: Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan. Clin Exp Nephrol 13: 38-43, 2009
18. Chan MK, Yin PD, Chan KW: Primary glomerulonephritis in Hong Kong. Int Urol Nephrol 20: 413-420, 1988
19. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF: All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 371: 2173-2182, 2008
20. Yang WC, Hwang SJ; Taiwan Society of Nephrology: Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: The impact of national health insurance. Nephrol Dial Transplant 23: 3977-3982, 2008
21. Heaf J: The Danish Renal Biopsy Register. Kidney Int 66: 895-897, 2004
22. Iseki K, Miyasato F, Uehara H, Tokuyama K, Toma S, Nishime K, Yoshi S, Shiohira Y, Oura T, Tozawa M, Fukiyama K: Outcome study of renal biopsy patients in Okinawa, Japan. Kidney Int 66: 914-919, 2004
23. Li LS, Liu ZH: Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies. Kidney Int 66: 920-923, 2004
24. Levey AS, Greene T, Kusek J, Beck GJ, Group MS: A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract). J Am Soc Nephrol 11: 155A, 2000
25. Saha TC, Singh H:Minimal change disease: A review. SouthMed J 99: 1264-1270, 2006
26. Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G: Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445-453, 2007
27. Korbet SM, Schwartz MM, Lewis EJ: Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. AmJ Kidney Dis 23: 773-783, 1994
28. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. Am J Kidney Dis 25: 534-542, 1995
29. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69: 920-926, 2006
30. Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF: Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population-epidemiology and outcome. Nephrol Dial Transplant 23: 186-192, 2008
31. Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD: Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 109: c109-c118, 2008
32. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
33. O'Callaghan CA, Hicks J, Doll H, Sacks SH, Cameron JS: Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol 33: 157-165, 2002
34. Cattran DC: Outcomes research in glomerulonephritis. Semin Nephrol 23: 340-354, 2003
35. Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K: Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy. Nephrology (Carlton) 14: 521-526, 2009
36. D'Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24: 179-196, 2004
37. Alaleh G, Hassan O, Abbas M: Prediction of kidney survival in children with primary focal segmental glomerulosclerosis (a twocenter study). JRMS 12: 107-111, 2007
38. Schnaper HW: Idiopathic focal segmental glomerulosclerosis. Semin Nephrol 23: 183-193, 2003
39. Marx BE, Marx M: Prediction in idiopathic membranous nephropathy. Kidney Int 56: 666-673, 1999
40. Glassock RJ: Diagnosis and natural course of membranous nephropathy. Semin Nephrol 23: 324-332, 2003
41. Syrjänen J, Mustonen J, Pasternack A: Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 15: 34-42, 2000
42. Lee PH, ChangHY, TungCW, Hsu YC, Lei CC, ChangHH, YangHF, Lu LC, Jong MC, Chen CY, Fang KY, Chao YS, Shih YH, Lin CL: Hypertriglyceridemia: An independent risk factor of chronic kidney disease in Taiwanese adults. AmJMed Sci 338: 185-189, 2009
43. Hadjadj S, Duly-Bouhanick B, Bekherraz A, BrIdoux F, Gallois Y, Mauco G, Ebran J, Marre M: Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 30: 43-51, 2004
44. Hofstra JM, Willems JL, Wetzels JFM: Estimated glomerular filtration rate in the nephrotic syndrome. Nephrol Dial Transplant 26: 550-556, 2011